Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial.

Subjects

Subjects :

Humans
Young Adult
Adult
Male
Female
Adolescent
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Leukemia, Myeloid, Acute therapy
Neoplasm, Residual

Details

Language :

English

ISSN :

2473-9537

Volume :

8

Issue :

16

Database :

MEDLINE

Journal :

Blood advances

Publication Type :

Academic Journal

Accession number :

38968139

Full Text :

https://doi.org/10.1182/bloodadvances.2024013182